RxDoctor Payments Data

Danielle Constandis

Acute Care · Newark, NJNPI 1609478684

Payments from drug & device makers

What this record shows

Medtronic accounts for 66.5% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2023 at $2,702 and has fallen 65.3% since, to $938 in 2025. Among acute care clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,648in general payments, 2019–2025

Across 122 payments — averaging $54.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$4K
  • Abiomed$751
  • Novartis$217
  • Alnylam Pharmaceuticals Inc.$198
  • Merck$197
  • AstraZeneca$140
  • plus $723 from 18 others

What the payments were for

  • Travel & lodging$3,25449%
  • Food & beverage$3,39451%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,648 in reported general payments places this provider in the 95th percentile of 656 acute care providers in New Jersey.

See all acute care providers in New Jersey

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sandostatin Lar DepotOctreotide Acetate,mi-Spheres26$127,268
EntrestoSacubitril/Valsartan15$13,444
Sildenafil Citrate16$10,828
Hydralazine Hcl23$804
Amiodarone Hcl15$797
Warfarin Sodium73$750
Potassium Chloride21$708
Metoprolol Succinate17$527
Pantoprazole Sodium32$475
Gabapentin22$318
Atorvastatin Calcium19$255
Doxycycline Hyclate12$235
Torsemide18$186
Spironolactone16$176
Carvedilol24$101

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisSandostatin Lar Depot, Entresto$217$140,71141 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 656 acute care providers in New Jersey.

Other acute care in Newark

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →